RxDoctor Payments Data

Francesca Ferraro, MD

Medical Oncology · Saint Louis, MONPI 1295173136

Payments from drug & device makers

$180,215in general payments, 2019–2025

Across 4 payments — averaging $45,054 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$180K
  • Incyte Corporation$90

What the payments were for

  • Food & beverage$12558%
  • Education$9042%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead(2 entities)3$180,125
Incyte Corporation1$90

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$180,215 in reported general payments places this provider in the 50th percentile of 144 medical oncology providers in Missouri.

See all medical oncology providers in Missouri

Medicare billing

Part B allowed, 2024
$19,840
Medicare patients
45
Services billed
239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →